High incidence and reversible bradycardia events following alectinib initiation

por Yuan, Dongqi, Zhu, Fuyi, Zuo, Ran, Wang, Yu, Huo, Gengwei, Cui, Jinfang, Yue, Ping, Chen, Peng
Publicado 2022

The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma

por Zuo, Ran, Zhu, Fuyi, Zhang, Cuicui, Ma, Jincheng, Chen, Jinliang, Yue, Ping, Cui, Jinfang, Wang, Yu, Chen, Peng
Publicado 2023

Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling

por Cui, Jinfang, Song, Yang, Han, Xuejiao, Hu, Jing, Chen, Yanbo, Chen, Xuesong, Xu, Xiaomin, Xing, Ying, Lu, Hailing, Cai, Li
Publicado 2020

A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors

por Huo, Gengwei, Wang, Yali, Chen, Jinliang, Song, Ying, Zhang, Cuicui, Guo, Hua, Zuo, Ran, Zhu, Fuyi, Cui, Jinfang, Chen, Weidong, Chen, Wenming, Chen, Peng
Publicado 2021

Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma

por Cui, Jinfang, He, Yuchao, Zhu, Fuyi, Gong, Wenchen, Zuo, Ran, Wang, Yu, Luo, Yi, Chen, Liwei, Wang, Chengmeng, Huo, Gengwei, Lu, Hailing, Liu, Zhiyong, Chen, Peng, Guo, Hua
Publicado 2023